Search Results - "Aberer, E."

Epidemiologic, socioeconomic and psychosocial aspects in lupus erythematosus by Aberer, E.

“…Epidemiologic, socioeconomic, and psychosocial factors play an important role in health care and handling of patients with the various clinical forms of lupus…”
Get full text

An open, multicentre, randomized clinical study in patients with bullous pemphigoid comparing methylprednisolone and azathioprine with methylprednisolone and dapsone by Sticherling, M., Franke, A., Aberer, E., Gläser, R., Hertl, M., Pfeiffer, C., Rzany, B., Schneider, S., Shimanovich, I., Werfel, T., Wilczek, A., Zillikens, D., Schmidt, E.

“…Summary Background Current treatment of bullous pemphigoid (BP) is based on the long‐term use of topical and/or systemic corticosteroids, which are associated…”
Get full text

S2k guideline for treatment of cutaneous lupus erythematosus – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV) by Kuhn, A., Aberer, E., Bata‐Csörgő, Z., Caproni, M., Dreher, A., Frances, C., Gläser, R., Klötgen, H.‐W., Landmann, A., Marinovic, B., Nyberg, F., Olteanu, R., Ranki, A., Szepietowski, J.C., Volc‐Platzer, B.

“…Cutaneous lupus erythematosus (CLE) is a rare inflammatory autoimmune disease with heterogeneous clinical manifestations. To date, no therapeutic agents have…”
Get full text

European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes by Knobler, R., Moinzadeh, P., Hunzelmann, N., Kreuter, A., Cozzio, A., Mouthon, L., Cutolo, M., Rongioletti, F., Denton, C.P., Rudnicka, L., Frasin, L.A., Smith, V., Gabrielli, A., Aberer, E., Bagot, M., Bali, G., Bouaziz, J., Braae Olesen, A., Foeldvari, I., Frances, C., Jalili, A., Just, U., Kähäri, V., Kárpáti, S., Kofoed, K., Krasowska, D., Olszewska, M., Orteu, C., Panelius, J., Parodi, A., Petit, A., Quaglino, P., Ranki, A., Sanchez Schmidt, J.M., Seneschal, J., Skrok, A., Sticherling, M., Sunderkötter, C., Taieb, A., Tanew, A., Wolf, P., Worm, M., Wutte, N.J., Krieg, T.

“…The term ‘sclerosing diseases of the skin' comprises specific dermatological entities, which have fibrotic changes of the skin in common. These diseases mostly…”
Get full text

Facets of shame are differently expressed in dermatological disease: a prospective observational study by Aberer, E., Hiebler‐Ragger, M., Zenker, M., Weger, W., Hofer, A., Unterrainer, H.F.

Get full text

European dermatology forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosis by Knobler, R., Moinzadeh, P., Hunzelmann, N., Kreuter, A., Cozzio, A., Mouthon, L., Cutolo, M., Rongioletti, F., Denton, C.P., Rudnicka, L., Frasin, L.A., Smith, V., Gabrielli, A., Aberer, E., Bagot, M., Bali, G., Bouaziz, J., Braae Olesen, A., Foeldvari, I., Frances, C., Jalili, A., Just, U., Kähäri, V., Kárpáti, S., Kofoed, K., Krasowska, D., Olszewska, M., Orteu, C., Panelius, J., Parodi, A., Petit, A., Quaglino, P., Ranki, A., Sanchez Schmidt, J.M., Seneschal, J., Skrok, A., Sticherling, M., Sunderkötter, C., Taieb, A., Tanew, A., Wolf, P., Worm, M., Wutte, N.J., Krieg, T.

“…The term ‘sclerosing diseases of the skin’ comprises specific dermatological entities which have fibrotic changes of the skin in common. These diseases mostly…”
Get full text

CXCL13 and B-cell activating factor as putative biomarkers in systemic sclerosis by Wutte, N., Kovacs, G., Berghold, A., Reiter, H., Aberer, W., Aberer, E.

Get full text

The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement by Hunzelmann, N., Genth, E., Krieg, T., Lehmacher, W., Melchers, I., Meurer, M., Moinzadeh, P., Müller-Ladner, U., Pfeiffer, C., Riemekasten, G., Schulze-Lohoff, E., Sunderkoetter, C., Weber, M., Worm, M., Klaus, P., Rubbert, A., Steinbrink, K., Grundt, B., Hein, R., Scharffetter-Kochanek, K., Hinrichs, R., Walker, K., Szeimies, R.-M., Karrer, S., Müller, A., Seitz, C., Schmidt, E., Lehmann, P., Foeldvári, I., Reichenberger, F., Gross, W.L., Kuhn, A., Haust, M., Reich, K., Böhm, M., Saar, P., Fierlbeck, G., Kötter, I., Lorenz, H.-M., Blank, N., Gräfenstein, K., Juche, A., Aberer, E., Bali, G., Fiehn, C., Stadler, R., Bartels, V.

“…Objective. Systemic sclerosis (SSc) is a rare, heterogeneous disease, which affects different organs and therefore requires interdisciplinary diagnostic and…”
Get full text

Large Variability of Frequency and Type of Physical Therapy in Patients in the German Network for Systemic Sclerosis by Belz, D., Moinzadeh, P., Riemekasten, G., Henes, J., Müller‐Ladner, U., Blank, N., Koetter, I., Siegert, E., Pfeiffer, C., Schmalzing, M., Zeidler, G., Schmeiser, T., Worm, M., Guenther, C., Susok, L., Kreuter, A., Sunderkoetter, C., Juche, A., Aberer, E., Gaebelein‐Wissing, N., Ramming, A., Kuhr, K., Hunzelmann, N.

“…Objective To determine the type and frequency of physical therapy (PT) prescribed by physicians for patients in the registry of the German Network for Systemic…”
Get full text

Paraneoplastic pemphigus in two pairs of brothers by Kranzelbinder, B., Hashimoto, T., Joch, M., Salmhofer, W., Reiter, H., Bauer, J., Aberer, E.

Get full text

The influence of religious/spiritual well-being on quality of life in dermatological disease by Unterrainer, H.F., Lukanz, M., Pilch, M., Scharf, S., Glawischnig-Goschnik, M., Wutte, N., Fink-Puches, R., Aberer, E.

Get full text

Anaphylaxis with clonal mast cells in normal looking skin – a new entity? by Bretterklieber, A., Beham‐Schmid, C., Sturm, G. J., Berghold, A., Brezinschek, R., Aberer, W., Aberer, E.

“…Background Patients with elevated basal tryptase (sBT) >15 μg/l and anaphylaxis may have an underlying mastocytosis. A monoclonal mast cell activation syndrome…”
Get full text

Treatment of livedoid vasculopathy with alprostadil (PGE-1): case report and review of published literature by Mofarrah, R., Aberer, W., Aberer, E.

Get full text

CXCL13 chemokine in pediatric and adult neuroborreliosis by Wutte, N., Berghold, A., Löffler, S., Zenz, W., Daghofer, E., Krainberger, I., Kleinert, G., Aberer, E.

“…Wutte N, Berghold A, Löffler S, Zenz W, Daghofer E, Krainberger I, Kleinert G, Aberer E. CXCL13 chemokine in pediatric and adult neuroborreliosis. 
Acta Neurol…”
Get full text

Spirituality and mood pathology in severe skin conditions: a prospective observational study by Unterrainer, Human-Friedrich, Lukanz, M., Pilch, M., Scharf, S., Glawischnig-Goschnik, M., Wutte, N., Fink-Puches, R., Aberer, E.

“…Although the association between spirituality and parameters of psychological health and disease has been investigated extensively, little evidence is…”
Get full text

Clonal mast cell proliferation in pruriginous skin in hypereosinophilic syndrome by Wiednig, M, Beham-Schmid, C, Kranzelbinder, B, Aberer, E

“…Hypereosinophilic syndrome (HES) is defined as a high eosinophilic granulocyte count in peripheral blood and other tissues. It can be associated with clonal…”
Get more information

Treatment failure with rituximab in a patient with pemphigus vulgaris by Weger, W, Aberer, E

Get full text

Progressive circumscribed sclerosis - a novel side-effect of immunotherapy with aluminium-adsorbed allergen extracts by El Shabrawi-Caelen, Poelt, P, Aberer, W, Aberer, E

“…In the susceptible patient aluminum may trigger an autoimmune reaction with progressive sclerosis as the key clinical feature…”
Get full text

Erythematous macules in a 14-year-old girl by Massone, C., Kopera, D., Aberer, E.

Get full text

Dermatological symptoms in rheumatology by Aberer, E

“…The connective tissue of the skin, joints and musculoskeletal system is often involved concomittantly in rheumatic diseases. Specific skin lesions can be the…”
Get full text